Absorption of Antibiotics With High Oral Bioavailability in Short-bowel Syndrome
Recruiting
Phase 1
Interventional Study
Short Bowel Syndrome
Infection, Bacterial
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 10 (estimated)
- Sponsor
- Central Hospital, Nancy, France · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The purpose of this study is to assess the drug absorption of oral antibiotics in patients with short bowel syndrome.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Short bowel syndrome
* Treated for a documented infection with antibiogram by amoxicillin (+/- clavulanic acid)or ofloxacin or levofloxacin or sulfamethoxazole/trimethoprim
* Hospitalized in the Nutritional Assistant Unit or the Infectiology Unit of the Regional University Hos…
Contacts